PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG TYPE 2 DIABETES MELLITUS PATIENTS: A MACHINE LEARNING TIME-TO-EVENT ANALYSIS

被引:0
|
作者
Icten, Z. [1 ]
Friedman, M. [2 ]
Menzin, J. [1 ]
机构
[1] Panalgo, Boston, MA USA
[2] Panalgo LLC, Boston, MA USA
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
P24
引用
收藏
页码:S291 / S292
页数:2
相关论文
共 50 条
  • [1] Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Nissen, SE
    Wolski, K
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (20): : 2581 - 2586
  • [2] Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes
    Abegaz, Tadesse M.
    Baljoon, Ahmead
    Kilanko, Oluwaseun
    Sherbeny, Fatimah
    Ali, Askal Ayalew
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 164
  • [3] Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Liyao Fu
    Ying Zhou
    Jiaxing Sun
    Zhaowei Zhu
    Zhenhua Xing
    Shenghua Zhou
    Yongjun Wang
    Shi Tai
    Cardiovascular Diabetology, 20
  • [4] Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Fu, Liyao
    Zhou, Ying
    Sun, Jiaxing
    Zhu, Zhaowei
    Xing, Zhenhua
    Zhou, Shenghua
    Wang, Yongjun
    Tai, Shi
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [5] Time-to-Event GWAS for Incident Cardiovascular Disease in Type 2 Diabetes Patients
    Kwak, Soo Heon
    Wu, Peitao
    Meigs, James B.
    DIABETES, 2021, 70
  • [6] MAJOR ADVERSE EVENTS WITH THE USE OF FINERENONE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Sviggou, Asimina
    Kordalis, Vasilios
    Aidinis, Asterios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Karagiannis, Asterios
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E158 - +
  • [7] N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus
    Sun, Mingyang
    Lu, Zhongyuan
    Chen, Wan-Ming
    Lv, Shuang
    Fu, Ningning
    Yang, Yitian
    Wang, Yangyang
    Miao, Mengrong
    Wu, Szu-Yuan
    Zhang, Jiaqiang
    ATHEROSCLEROSIS, 2025, 402
  • [8] Triglyceride-glucose related indices as predictors for major adverse cardiovascular events and overall mortality in type-2 diabetes mellitus patients
    Liu, Mao-Jun
    Pei, Jun-Yu
    Zeng, Cheng
    Xing, Ying
    Zhang, Yi-Feng
    Tang, Pei-Qi
    Deng, Si-Min
    Hu, Xin-Qun
    WORLD JOURNAL OF DIABETES, 2025, 16 (03)
  • [9] Social isolation, loneliness and subsequent risk of major adverse cardiovascular events among individuals with type 2 diabetes mellitus
    Liang, Yannis Yan
    Chen, Yilin
    Feng, Hongliang
    Xue, Huachen
    Nie, Yu
    Ai, Qi-Yong H.
    Ma, Jiacheng
    Yang, Lulu
    Zhang, Jihui
    Ai, Sizhi
    GENERAL PSYCHIATRY, 2023, 36 (06)
  • [10] HEART Score Classification of Major Adverse Cardiovascular Events in Patients with Diabetes Mellitus
    Alhamaydeh, Mohammad
    Helman, Stephanie
    AlQaqaa, Ahmed
    Luo, Huabin
    Al-Zaiti, Salah
    CIRCULATION, 2024, 150